Markus Cybulla

1.5k total citations
31 papers, 949 citations indexed

About

Markus Cybulla is a scholar working on Physiology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Markus Cybulla has authored 31 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Pathology and Forensic Medicine and 7 papers in Epidemiology. Recurrent topics in Markus Cybulla's work include Lysosomal Storage Disorders Research (15 papers), Biomedical Research and Pathophysiology (9 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). Markus Cybulla is often cited by papers focused on Lysosomal Storage Disorders Research (15 papers), Biomedical Research and Pathophysiology (9 papers) and Glycogen Storage Diseases and Myoclonus (5 papers). Markus Cybulla collaborates with scholars based in Germany, Italy and Austria. Markus Cybulla's co-authors include Andreas Otte, Stefan M. Weiner, Sandro Feriozzi, Gere Sunder‐Plassmann, Michael L. West, Hartmut P.H. Neumann, Andreas Schwarting, Joan Torrás, Kathy Nicholls and Wolfgang Grotz and has published in prestigious journals such as PLoS ONE, Annals of the New York Academy of Sciences and Journal of the American Society of Nephrology.

In The Last Decade

Markus Cybulla

31 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Cybulla Germany 16 367 276 215 214 151 31 949
Tamotsu Yokozawa Japan 25 87 0.2× 218 0.8× 331 1.5× 527 2.5× 29 0.2× 46 2.2k
C.J.M. Lips Netherlands 18 156 0.4× 269 1.0× 275 1.3× 372 1.7× 43 0.3× 37 1.2k
Tatiana Prokaeva United States 16 224 0.6× 84 0.3× 261 1.2× 1.2k 5.4× 220 1.5× 39 1.3k
Hisashi Hasumi Japan 20 187 0.5× 72 0.3× 173 0.8× 700 3.3× 39 0.3× 73 1.4k
Thiago Trovati Maciel France 15 138 0.4× 55 0.2× 78 0.4× 394 1.8× 59 0.4× 38 898
MA Gertz United States 19 121 0.3× 301 1.1× 450 2.1× 1.4k 6.4× 322 2.1× 32 1.7k
Vincent Algalarrondo France 22 100 0.3× 98 0.4× 145 0.7× 794 3.7× 131 0.9× 83 1.5k
Salvatore Di Lauro Italy 16 66 0.2× 61 0.2× 231 1.1× 303 1.4× 25 0.2× 54 1.1k
Robert Rzepko Poland 16 70 0.2× 165 0.6× 200 0.9× 205 1.0× 17 0.1× 44 711
Mingguo Huang Japan 20 96 0.3× 93 0.3× 212 1.0× 433 2.0× 20 0.1× 51 1.1k

Countries citing papers authored by Markus Cybulla

Since Specialization
Citations

This map shows the geographic impact of Markus Cybulla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Cybulla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Cybulla more than expected).

Fields of papers citing papers by Markus Cybulla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Cybulla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Cybulla. The network helps show where Markus Cybulla may publish in the future.

Co-authorship network of co-authors of Markus Cybulla

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Cybulla. A scholar is included among the top collaborators of Markus Cybulla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Cybulla. Markus Cybulla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lenders, Malte, Albina Nowak, Markus Cybulla, et al.. (2025). Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease. Orphanet Journal of Rare Diseases. 20(1). 79–79. 4 indexed citations
2.
Lenders, Malte, Albina Nowak, Markus Cybulla, et al.. (2024). Impact of enzyme replacement therapy on clinical manifestations in females with Fabry disease. Orphanet Journal of Rare Diseases. 19(1). 490–490. 4 indexed citations
3.
Müntze, Jonas, Markus Cybulla, Eva Brand, et al.. (2022). Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter study. Molecular Genetics and Metabolism. 138(2). 106981–106981. 15 indexed citations
4.
Liebau, Max C., Fabian Braun, Katja Höpker, et al.. (2013). Dysregulated Autophagy Contributes to Podocyte Damage in Fabry’s Disease. PLoS ONE. 8(5). e63506–e63506. 105 indexed citations
5.
Feriozzi, Sandro, Joan Torrás, Markus Cybulla, et al.. (2012). The Effectiveness of Long-Term Agalsidase Alfa Therapy in the Treatment of Fabry Nephropathy. Clinical Journal of the American Society of Nephrology. 7(1). 60–69. 63 indexed citations
6.
Cybulla, Markus, Christine Kurschat, Michael L. West, et al.. (2012). Kidney transplantation and enzyme replacement therapy in patients with Fabry disease. Journal of Nephrology. 26(4). 645–651. 14 indexed citations
7.
Neumann, Hartmut P.H., Michael M. Hoffmann, Elke Schäeffner, et al.. (2012). Adult patients with sporadic polycystic kidney disease: the importance of screening for mutations in the PKD1 and PKD2 genes. International Urology and Nephrology. 44(6). 1753–1762. 16 indexed citations
8.
Cybulla, Markus, et al.. (2009). Kidney transplantation in patients with Fabry disease. Transplant International. 22(4). 475–481. 30 indexed citations
9.
Feriozzi, Sandro, Andreas Schwarting, Gere Sunder‐Plassmann, Michael L. West, & Markus Cybulla. (2008). Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease. American Journal of Nephrology. 29(5). 353–361. 53 indexed citations
10.
Cybulla, Markus, Walter K.K. Ho, H. Neumann, et al.. (2007). Morbus Fabry: Demografische Übersicht seit Einführung der Enzymersatztherapie. DMW - Deutsche Medizinische Wochenschrift. 132(28/29). 1505–1509. 8 indexed citations
11.
Cybulla, Markus & Hartmut P.H. Neumann. (2007). Morbus Fabry. DMW - Deutsche Medizinische Wochenschrift. 132(43). 2271–2277. 2 indexed citations
12.
Bausch, Birke, Carsten C. Boedeker, Ansgar Berlis, et al.. (2006). Genetic and Clinical Investigation of Pheochromocytoma. Annals of the New York Academy of Sciences. 1073(1). 122–137. 14 indexed citations
13.
Cybulla, Markus, Hao Ling, Stefan Kröber, et al.. (2005). Chronic Renal Failure and Proteinuria in Adulthood: Fabry Disease Predominantly Affecting the Kidneys. American Journal of Kidney Diseases. 45(5). e82–e89. 16 indexed citations
14.
Neumann, Hartmut P.H., Markus Cybulla, Hirotaka Shibata, et al.. (2005). New genetic causes of pheochromocytoma: current concepts and the clinical relevance. The Keio Journal of Medicine. 54(1). 15–21. 10 indexed citations
15.
Cybulla, Markus, et al.. (2004). When to Look for Von Hippel-Lindau Disease in Gastroenteropancreatic Neuroendocrine Tumors?. Neuroendocrinology. 80(Suppl. 1). 39–46. 6 indexed citations
16.
Lambert, Bieke, Markus Cybulla, Stefan M. Weiner, et al.. (2004). Renal Toxicity after Radionuclide Therapy. Radiation Research. 161(5). 607–611. 67 indexed citations
17.
Grotz, W, et al.. (2001). Immunosuppression and skeletal disorders. Transplantation Proceedings. 33(1-2). 992–993. 8 indexed citations
18.
Cybulla, Markus, Stefan M. Weiner, & Andreas Otte. (2001). End-stage renal disease after treatment with 90 Y-DOTATOC. European Journal of Nuclear Medicine and Molecular Imaging. 28(10). 1552–1554. 114 indexed citations
19.
Hildebrandt, Friedhelm, et al.. (1996). Glomerulopathy associated with predominant fibronectin deposits: Exclusion of the genes for fibronectin, villin and desmin as causative genes. American Journal of Medical Genetics. 63(1). 323–327. 16 indexed citations
20.
Hildebrandt, Friedhelm, Markus Cybulla, Brigitte Strahm, et al.. (1996). Physical mapping of the gene for juvenile nephronophthisis (NPH1) by construction of a complete YAC contig of 7 Mb on chromosome 2q13. Cytogenetic and Genome Research. 73(3). 235–239. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tamotsu Yokozawa Breakdown of academic impact, for papers by C.J.M. Lips Breakdown of academic impact, for papers by Tatiana Prokaeva Breakdown of academic impact, for papers by Hisashi Hasumi Breakdown of academic impact, for papers by Thiago Trovati Maciel Breakdown of academic impact, for papers by MA Gertz Breakdown of academic impact, for papers by Vincent Algalarrondo Breakdown of academic impact, for papers by Salvatore Di Lauro Breakdown of academic impact, for papers by Robert Rzepko Breakdown of academic impact, for papers by Mingguo Huang
Rankless by CCL
2026